BLFE

COM:BIOLIFESCIENCES

BioLife Sciences

Stock

USD

Market Cap

118

Beta: -

Volume Today

50

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Nov '19	Nov '20
account payables		492.68K -
accumulated other comprehensive income loss		-35.86K -
cash and cash equivalents	17 -	34.74K 204,252.94%
cash and short term investments	17 -	34.74K 204,252.94%
common stock		5.49K -
deferred revenue
deferred revenue non current
deferrred tax liabilities non current
goodwill
goodwill and intangible assets
intangible assets
inventory
long term debt
long term investments
net debt	-17 -	154.85K 910,970.59%
net receivables
other assets
other current assets		36.99K -
other current liabilities	1.17K -	80.03K 6,734.42%
other liabilities
other non current assets		0.00 -
other non current liabilities
othertotal stockholders equity		609.68K -
preferred stock
property plant equipment net		991.00 -
retained earnings	-1.15K -	-1.27M 109,856.15%
short term debt		189.59K -
short term investments
tax assets
tax payables
total assets	17 -	72.72K 427,652.94%
total current assets	17 -	71.73K 421,823.53%
total current liabilities	1.17K -	762.30K 64,998.29%
total debt		189.59K -
total investments
total liabilities	1.17K -	762.30K 64,998.29%
total liabilities and stockholders equity	17 -	72.72K 427,652.94%
total non current assets		991.00 -
total non current liabilities
total stockholders equity	-1.15K -	-689.58K 59,655.89%

All numbers in USD (except ratios and percentages)